RedHill Biopharma reported $400K in Market Capitalization this November of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Cara Therapeutics USD 30M 336M Mar/2026
Clal Biotechnology ILS 52.36M 2.09M Mar/2025
Compugen USD 564.53M 41.47M Nov/2026
Cronos Group USD 2B 781.98M Nov/2026
RedHill Biopharma USD 8M 3M Jun/2026